Type 2 diabetes with other specified/multiple/unspecified complications

E4_DM2NASCOMP

No definition available.

Endpoint definition

FinnGen phenotype data

356077 individuals

diagram downward connector

Apply sex-specific rule None

356077

diagram downward connector

Check conditions None

356077

diagram downward connector
diagram bullet

Filter registries

Hospital Discharge: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8
Hospital discharge: ICD-9 2507A|2508A
Hospital discharge: ICD-8 $!$
Cause of death: ICD-10 E11.6, E11.6+M14.2, E11.6+M14.6, E11.7, E11.8
Cause of death: ICD-9 2507A|2508A
Cause of death: ICD-8 $!$
KELA reimbursements: KELA codes ANY
KELA reimbursements: ICD-10 E11

197328

diagram downward connector
diagram bullet

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

41714

diagram downward connector

Check minimum number of events None

41714

diagram downward connector

Include endpoints None

41714

diagram downward connector
E4_DM2NASCOMP

Extra metadata

Level in the ICD hierarchy 4
First used in FinnGen datafreeze DF3

Summary Statistics

Key figures

All Female Male
Number of individuals 41714 17882 23832
Unadjusted prevalence (%) 11.72 9.01 15.14
Mean age at first event (years) 61.74 61.04 62.27

Mortality

Follow-up Absolute risk HR [95% CI] p N
1998–2019 0.05 3.02 [2.64, 3.44] 1.8e-59 6877
15 years 0.01 1.85 [1.66, 2.06] 2.6e-29 3251
5 years 0.00 3.17 [2.91, 3.46] <1e-100 2010
1 year 0.00 7.42 [6.62, 8.32] <1e-100 912

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

Index endpoint: E4_DM2NASCOMP – Type 2 diabetes with other specified/multiple/unspecified complications
GWS hits: 175

Survival analyses between endpoints

Plot

before Type 2 diabetes with other specified/multiple/unspecified complications
after Type 2 diabetes with other specified/multiple/unspecified complications

loading spinner Loading survival analyses plot

Drugs most likely to be purchased after Type 2 diabetes with other specified/multiple/unspecified complications